Many medications can cause hair loss, including certain blood pressure medications, antidepressants, and anticoagulants
Constipation related to GLP-1 therapy is not a sign of treatment failure but rather a predictable consequence of the medication's mechanism
The opportunities in these indications can be assessed by deploying effective new product planning / opportunity assessment methodologies, including evaluating the following for each potential indication: Level of in-class / competitive activity Likelihood of technical and regulatory success (i.e., based on scientific rationale and regulatory precedent) Level and nature of unmet needs for new therapies in the disease area of interest Potential for GLP1-s to address these unmet needs Commercial attractiveness of market Potential speed to market Alignment with individual manufacturer portfolio / strategy / capabilities Conclusion Incretin mimetics have had an immense and growing impact on patient outcomes
Based on the results mentioned above, GLP-1 related signaling pathways have been corroborated as promising strategies to prevent and treat AD
suppress the immunity, active glutathione (GSH) works to modulate the behaviour of immune cells and turn on the immunity
What Exactly is L-Carnitine